Personality disorders personality problems
Conditions
Interventions
Within the experimental condition TE-ST is provided consisting of 18 90-minute group sessions and two 60 minute follow up sessions. Experiential techniques like imagery, imagery with rescripting, hist
Sponsors
Parnassia
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: 1. DSM-5 classification of a personality disorder preferably assessed with the aid of the Structured Clinical Interview of DSM-5 Disorders (SCID-5-P, Arntz, Kamphuis & Derks, 2017). The SCID-5-P is part of the standard admission procedure for specialised care. A different standardised assessment may be used. 2. Age at least 18 years, 3. Eligibility for group therapy based on; a. symptoms of personality disorders are the reason for seeking help, b. the patient is motivated to follow psychotherapy in a group, and c. the clinical judgement of the group therapists. The latter is based on the patient ability to attend group meetings, the patient openness within a group and the patient reflective ability given the input of other patients.
Exclusion criteria
Exclusion criteria: 1. Acute crisis (such as suicidality) for which a patient needs inpatient treatment, 2. Acute psychotic episode or psychotic disorder, autism spectrum disorder or alcohol or drugs-related disorders as primary diagnosis, 3. Limited knowledge of the Dutch language, 4. Severe auditory problems that interfere with participation in a group, or severe stuttering, 5. Estimated IQ below 70.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study parameter is the level of personality functioning as measured by the Level of Personality Functioning Scale - Brief Form (LPFS-BF). It is tested whether TE-ST is non-inferior to long term group schema therapy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objectives to the study are: to explore the effect on decreasing the severity of general psychiatric complaints (Brief Symptom Inventory), personality disorder symptoms (PID-5-BF) of time-limited compared to long-term group schema therapy; to understand the effect of increasing emotion regulation ability (DERS), and improving functioning (WHODAS-2) and quality of life (MHQOL) of time-limited compared to long-term group schema therapy; to understand the effectiveness of therapy from the patient's perspective using patient derived goals in time-limited compared to long-term group schema therapy; to estimate the cost-effectiveness (TIC-P/EQ-5D-5L) of time-limited compared to long-term group schema therapy; to understand what factors are predictive in therapy outcome (CTQ, YSQ, SMI, DES-T). | — |
Countries
Netherlands
Contacts
Public ContactA.W.J. Hoogenboom
Parnassia
Outcome results
None listed